Haleon (HLN)

• Market cap: $44.5B
• 1 day: 0.7%
• 5 days: 1.3%
• 1 month: -1.56%
• 3 months: 9.77%
• 6 months: -6.99%
• Year to date: 1.1%
• 1 year: 4.33%
• 5 years: 34.8%
• 10 years: 34.8%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Employees: 24,524